These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8961461)

  • 1. Optimal sample allocation in clinical trials designed to investigate relative risks.
    Eastwood BJ
    Stat Med; 1996 Dec; 15(23):2523-38. PubMed ID: 8961461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward rapproachment in the placebo control debate. A calculated compromise of power.
    Leon AC; Solomon DA
    Eval Health Prof; 2003 Dec; 26(4):404-14. PubMed ID: 14631611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A two-stage sample size recalculation procedure for placebo- and active-controlled non-inferiority trials.
    Schwartz TA; Denne JS
    Stat Med; 2006 Oct; 25(19):3396-406. PubMed ID: 16900573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sample size determination for comparing several survival curves with unequal allocations.
    Halabi S; Singh B
    Stat Med; 2004 Jun; 23(11):1793-815. PubMed ID: 15160409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The fallacy of enrolling only high-risk subjects in cancer prevention trials: is there a "free lunch"?
    Baker SG; Kramer BS; Corle D
    BMC Med Res Methodol; 2004 Oct; 4():24. PubMed ID: 15461821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementing a decision-theoretic design in clinical trials: why and how?
    Palmer CR; Shahumyan H
    Stat Med; 2007 Nov; 26(27):4939-57. PubMed ID: 17582801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
    Woods SW; Gueorguieva RV; Baker CB; Makuch RW
    Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sample size determination in step-up testing procedures for multiple comparisons with a control.
    Kwong KS; Cheung SH; Wen MJ
    Stat Med; 2010 Nov; 29(26):2743-56. PubMed ID: 20799258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sample size determination for assessing equivalence based on proportion ratio under a randomized trial with non-compliance and missing outcomes.
    Lui KJ; Chang KC
    Stat Med; 2008 Jan; 27(1):47-67. PubMed ID: 17708514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative efficiency of unequal versus equal cluster sizes in cluster randomized and multicentre trials.
    van Breukelen GJ; Candel MJ; Berger MP
    Stat Med; 2007 Jun; 26(13):2589-603. PubMed ID: 17094074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allocation of patients to conditions in headache clinical trials: randomization, stratification, and treatment matching.
    Lipchik GL; Nicholson RA; Penzien DB
    Headache; 2005 May; 45(5):419-28. PubMed ID: 15953258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New algorithm for treatment allocation reduced selection bias and loss of power in small trials.
    Hofmeijer J; Anema PC; van der Tweel I
    J Clin Epidemiol; 2008 Feb; 61(2):119-24. PubMed ID: 18177784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dropout rates in placebo-controlled and active-control clinical trials of antipsychotic drugs: a meta-analysis.
    Kemmler G; Hummer M; Widschwendter C; Fleischhacker WW
    Arch Gen Psychiatry; 2005 Dec; 62(12):1305-12. PubMed ID: 16330718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Random allocation software for parallel group randomized trials.
    Saghaei M
    BMC Med Res Methodol; 2004 Nov; 4():26. PubMed ID: 15535880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of selection bias in parallel-group controlled clinical trials in dogs and cats: 97 trials (2000-2005).
    Brown DC
    J Am Vet Med Assoc; 2006 Sep; 229(6):990-3. PubMed ID: 16978121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal design of clinical trials comparing several treatments with a control.
    Marschner IC
    Pharm Stat; 2007; 6(1):23-33. PubMed ID: 17323312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trials in urology: how many patients are required to achieve statistically significant results?
    Parazzini F; Colli E; Chatenoud L; Malvezzi M; Olivieri L; Montorsi F; La Vecchia C
    BJU Int; 2005 Apr; 95(5):717-22. PubMed ID: 15784083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sample size calculations for 3-level cluster randomized trials.
    Teerenstra S; Moerbeek M; van Achterberg T; Pelzer BJ; Borm GF
    Clin Trials; 2008; 5(5):486-95. PubMed ID: 18827041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-inferiority trials: design concepts and issues - the encounters of academic consultants in statistics.
    D'Agostino RB; Massaro JM; Sullivan LM
    Stat Med; 2003 Jan; 22(2):169-86. PubMed ID: 12520555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomization procedures in orthopaedic trials.
    Randelli P; Arrigoni P; Lubowitz JH; Cabitza P; Denti M
    Arthroscopy; 2008 Jul; 24(7):834-8. PubMed ID: 18589273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.